John D McCracken

Title: John D McCracken: Innovator in Colon Cancer Detection

Introduction

John D McCracken is a notable inventor based in Redlands, CA (US), recognized for his contributions to medical diagnostics. He holds a total of six patents, showcasing his innovative approach to healthcare solutions. His work primarily focuses on methods for detecting colon cancer, which is a critical area in medical research.

Latest Patents

One of McCracken's latest patents is a method of detecting colon cancer through an immunological assay and kit designed for colon cancer screening. This innovative approach involves extracting fecal glycoproteins from individual samples while maintaining their immunogenicity. The purified fecal glycoproteins are then reacted with antibodies to the Colon and Ovarian Tumor Antigen (COTA). The mucin antigen COTA is specifically present in colorectal cancer tissue and absent in normal colons. By determining the amount of COTA in the fecal sample, this method can indicate the presence of colon cancer effectively.

Career Highlights

Throughout his career, McCracken has made significant strides in the field of medical diagnostics. His work at Loma Linda University has been instrumental in advancing research and development in cancer detection technologies. His innovative methods have the potential to improve early detection and treatment outcomes for patients.

Collaborations

McCracken has collaborated with notable professionals in his field, including William J Wechter and Keshab D Pant. These collaborations have contributed to the development of his patented technologies and have enhanced the impact of his work in the medical community.

Conclusion

John D McCracken's contributions to the field of colon cancer detection through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for advancements in medical diagnostics, ultimately benefiting patients and the medical community alike.